JPRN-jRCT2080225143已完成1 期
A Phase 1 Study of S-637880 - Investigation of the effects of multiple doses, and the drug-drug interaction with midazolam
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 55age old（—）
- 性别
- All
入选标准
- •Healthy adult Japanese or Caucasian, male or female subjects
排除标准
- •Subjects who are considered ineligible for this study by the investigator or subinvestigator due to history of metabolic, endocrine, hepatic, renal, pulmonary, hematological, cardiovascular, gastrointestinal, urological, immune, neurological, or psychiatric disorders.
研究者
相似试验
已完成
1 期
A phase I study (investigator-initiated) on the safety and pharmacokinetics of Bortezomib with combination chemotherapy in pediatric and young adult patients with refractory acute lymphocytic leukemiaRefractory acute lymphocytic leukemia(ALL) in children and young adultsJPRN-UMIN000015980St.Luke's International Hospital Daisuke Hasegawa National Hospital Organization Nagoya Medical Center Naoko Maeda Fukushima Medical University Hospital Atsushi Kikuta3
进行中（未招募）
1 期
A Study to Determine the Activity of SCH 717454 in Subjects With Osteosarcoma or Ewing’s Sarcoma That Has Relapsed After Standard Systemic Therapy. - P04720EUCTR2007-005341-38-FRSchering Plough Research Institute219
已完成
不适用
A Study to Determine the Activity of SCH 717454 in Subjects With Osteosarcoma or Ewing’s Sarcoma That Has Relapsed After Standard Systemic Therapy.PER-034-08SCHERING PLOUGH RESEARCH INSTITUTE,3
进行中（未招募）
不适用
A Study to Determine the Activity of SCH 717454 in Subjects With Osteosarcoma or Ewing’s Sarcoma That Has Relapsed After Standard Systemic Therapy. - P04720Relapsed resectable and unresectable Osteosarcoma, Ewing Sarcoma.MedDRA version: 12.0Level: LLTClassification code 10031293Term: Osteosarcoma localisedMedDRA version: 12.0Level: LLTClassification code 10015560Term: Ewing's sarcomaEUCTR2007-005341-38-PTSchering Plough Research Institute222
进行中（未招募）
1 期
A Study to Determine the Activity of SCH 717454 in Subjects With Osteosarcoma or Ewing’s Sarcoma That Has Relapsed After Standard Systemic Therapy. - P04720Relapsed resectable and unresectable Osteosarcoma, Ewing Sarcoma.EUCTR2007-005341-38-CZSchering Plough Research Institute219